Target intelligence / Profile preview

Ubiquitin-associated protein 1 (UBAP1)

Target
UBAP1
Molecular classification
Ubiquitin-binding protein (UBA domain family), Endosomal sorting complex subunit (ESCRT-I)
01

Overview

Ubiquitin-associated protein 1 (UBAP1) is a member of the ubiquitin-associated domain (UBA) family and a stable subunit of the ESCRT-I complex, which mediates endosomal sorting and degradation of ubiquitinated membrane proteins[1][2][4][5]. UBAP1 contains a unique C-terminal domain called SOUBA (solenoid of overlapping UBAs), which binds ubiquitin and is essential for ESCRT-I function in endosomal cargo sorting[1]. UBAP1 is required for degradation of certain antiviral proteins at the cell surface and is actively hijacked by viral immunomodulatory proteins[1]. Genetic mutations in UBAP1 disrupt endosomal dynamics, leading to accumulation of ubiquitinated proteins and are linked to juvenile-onset hereditary spastic paraplegia (SPG80) and frontotemporal lobar degeneration[2][3]. Its role in cellular housekeeping and neurodegeneration makes it an area of interest for understanding disease mechanisms and potential therapeutics. There are no drugs currently approved targeting UBAP1 directly, but it is under investigation as a therapeutic target and disease biomarker[1][2][3].

Other names
UBAP1Ubiquitin-associated protein 1NAG20Nasopharyngeal carcinoma-associated gene 20 proteinSPG80UAPUBAPUBAP-1
02

Mechanism of action

Drugs or molecules targeting this molecule would likely modulate ubiquitin-binding, endosomal trafficking, and degradation of membrane cargo

03

Biological functions

Endosomal sorting of ubiquitinated cargoMultivesicular body (MVB) biogenesisDegradation of cell-surface receptors and antiviral proteins (e.g., tetherin)Regulation of neuronal endosomal dynamics
04

Disease associations

Cancer (nasopharyngeal carcinoma, others)Neurodegenerative diseases (hereditary spastic paraplegia, SPG80, frontotemporal lobar degeneration)Putative role in additional disorders with endosomal dysfunction
05

Safety considerations

As a fundamental sorting and degradation protein, inhibition or mutation can lead to neurodegeneration (e.g., hereditary spastic paraplegia) and potentially widespread cellular dysfunction
06

Biomarkers

UBAP1 gene mutation status (frameshift, truncating mutations)Accumulation of ubiquitinated proteins in neurons

Beyond the preview

Go deeper on Ubiquitin-associated protein 1 (UBAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-associated protein 1 (UBAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call